Credit, Market, and Business Continuity Risks from COVID-19
First written in FY2021-Q3. 6 of 10 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 14 of 39 companies on the "Worse" side.
10 other companies' latest entry also says "Dropped".
- FY2026DroppedAnnual report
「Situations far exceeding assumptions relating to natural disasters, including torrential rain disasters, and infectious diseases occurred」
COVID-19 is no longer described as an individual major risk, and infectious disease risk has been classified as a general business continuity risk alongside natural disasters and other risks. - FY2024SoftenedAnnual report
「Although COVID-19 was reclassified as a Category 5 infectious disease at the end of the current consolidated fiscal year, the allowance for doubtful accounts was calculated based on the continuing assumption that, taking into account the effects of previous fiscal years, credit risk is likely to materialize for borrowers in certain industries.」
While the significance of the disease was reduced by its reclassification as a Category 5 disease, the credit risk assumptions reflecting the effects of previous fiscal years remain in place. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “Part 5 Accounting Status, 1 Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the securities report for the previous consolidated fiscal year.」
The Group has reconfirmed that there have been no material changes to the assumptions used in accounting estimates relating to COVID-19. - FY2023-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “Part 5 Accounting Status, 1 Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the securities report for the previous consolidated fiscal year.」
The Group has reconfirmed that there have been no material changes to the assumptions used in accounting estimates relating to COVID-19. - FY2023-Q1RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “Part 5 Accounting Status, 1 Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the securities report for the previous consolidated fiscal year.」
The Group has reconfirmed that there have been no material changes to the assumptions used in accounting estimates relating to COVID-19. - FY2022RestatedAnnual report
「Despite infection prevention measures implemented by governments around the world, COVID-19 continues to spread globally and is adversely affecting economic activity.」
The potential spillover effects of the spread of the disease on credit, market and liquidity risks, business activities, securing human resources, reputation, and the capital adequacy ratio continue to be treated as particularly important risks. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “Part 5 Accounting Status, 1 Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the securities report for the previous consolidated fiscal year.」
The company has reconfirmed that there have been no material changes to the assumptions underlying its accounting estimates related to COVID-19. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the assumptions, including assumptions regarding the future spread and timing of containment of COVID-19, described in “Part 5 Accounting Status, 1 Consolidated Financial Statements, Notes (Significant Accounting Estimates)” of the securities report for the previous consolidated fiscal year.」
The company has reconfirmed that there have been no material changes to the assumptions underlying its accounting estimates related to COVID-19. - FY2021MaterialisedAnnual report
「Credit costs increased by ¥6.8 billion year on year to ¥11.2 billion, reflecting both the impact of the spread of COVID-19 and additional precautionary provisions for certain business partners.」
The impact of COVID-19 is reflected in the financial results through deterioration in counterparties’ credit conditions and an increase in credit costs. - FY2021-Q3First statedAnnual report
「The spread of COVID-19 remains without a clear prospect of containment, and concerns remain about its long-term impact on the global economy amid an uncertain outlook.」
The disclosure states that impacts on retail and services, food service, accommodation, and tourism have become apparent, with spillover effects on credit risk, market and liquidity risk, disruption of business activities, securing human resources, and reputational risk.